MedTrace Logo

Systematic Review and Meta-Analysis on DCB vs. POBA in De-novo Femoropopliteal Disease

NCT02927574 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2020-03-10

No results posted yet for this study

Summary

Restenosis is still an issue after endovascular revascularization for femoropopliteal occlusive disease. One approach to reduce the rates of restenosis and reintervention is local application of Paclitaxel with drug-coated balloon angioplasty. The purpose is to conduct a systematic review and meta-analysis of randomized-controlled trials comparing on Drug-Coated Balloon angioplasty (DCB) vs. Plain Old Balloon Angioplasty (POBA) in de-novo femoropopliteal disease.

Conditions

  • Peripheral Arterial Disease
  • Intermittent Claudication

Interventions

DEVICE

DCB

DEVICE

POBA

Sponsors & Collaborators

  • Jena University Hospital

    lead OTHER

Principal Investigators

  • Ulf Teichgräber, Prof. · University Hospital Jena

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-09-30
Completion
2017-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02927574 on ClinicalTrials.gov